SYNTHESIS OF 1-[ω-(BROMOPHENOXY)ALKYL]-3-NAPHTHALENYLMETHYL DERIVATIVES OF URACIL AND THEIR ANALOGUES AS PROBABLE INHIBITORS OF HUMAN CYTOMEGALOVIRUS REPLICATION

M. P. Paramonova; Парамонова М. П.; E. S. Gureeva; Гуреева Е. С.; A. A. Ozerova; Озеров А. А.; R. Snoeck; Snoeck R.; G. Andrei; Andrei G.; D. A. Alexandrov; Александров Д. А.; A. L. Khandazhinskaya; Хандажинская А. Л.; M. S. Novikova; Новиков М. С.; S. N. Kochetkov; Кочетков С. Н.

doi:10.31857/S2686738922700044

SYNTHESIS OF 1-[ω-(BROMOPHENOXY)ALKYL]-3-NAPHTHALENYLMETHYL DERIVATIVES OF URACIL AND THEIR ANALOGUES AS PROBABLE INHIBITORS OF HUMAN CYTOMEGALOVIRUS REPLICATION

Authors: Paramonova M.P.¹, Gureeva E.S.¹, Ozerova A.A.¹, Snoeck R.², Andrei G.², Alexandrov D.A.³, Khandazhinskaya A.L.⁴, Novikova M.S.¹, Kochetkov S.N.⁴
Affiliations:
1. Volgograd State Medical University
2. Rega Institute for Medical Research, KU Leuven
3. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
4. V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences
Issue: Vol 508, No 1 (2023)
Pages: 35-40
Section: Articles
URL: https://vestnik.nvsu.ru/2686-7389/article/view/651147
DOI: https://doi.org/10.31857/S2686738922700044
EDN: https://elibrary.ru/MJOYWY
ID: 651147

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract

A new series of 1-[ω-(bromophenoxy) has been synthesizedalkyl]-uracil derivatives containing naphthalene-1-yl-, naphthalene-2-yl-, 1-brominaphthalene-2-ilmethyl, benzyl and anthracene-9-ilmethyl fragments in position 3 of uracil. Antiviral properties of synthesized compounds against human cytomegalovirus were studied. It was found that the compound, which has a bridge consisting of five methylene groups, has high anti-cytomegalovirus activity in vitro. uracil

Keywords

derivatives, synthesis, antiviral activity, human cytomegalovirus

About the authors

M. P. Paramonova

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

E. S. Gureeva

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

A. A. Ozerova

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

R. Snoeck

Rega Institute for Medical Research, KU Leuven

Email: khandazhinskaya@bk.ru
Belgium, B-3000, Leuven, Herestraat 49 bus 1043

G. Andrei

Rega Institute for Medical Research, KU Leuven

Email: khandazhinskaya@bk.ru
Belgium, B-3000, Leuven, Herestraat 49 bus 1043

D. A. Alexandrov

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

Email: khandazhinskaya@bk.ru
Russian Federation, Moscow

A. L. Khandazhinskaya

V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Author for correspondence.
Email: khandazhinskaya@bk.ru
Russian Federation, Moscow

M. S. Novikova

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

S. N. Kochetkov

V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Email: khandazhinskaya@bk.ru
Russian Federation, Moscow

References

Rodríguez-Goncer I., Fernández-Ruiz M., Aguado J.M. // Expert Rev. Anti. Infect. Ther. 2020. V. 18. P. 113–125.
Karrer U., Mekker A., Wanke K., Tchang V., Haeberli L. // Exp. Gerontol. 2009. V. 44. P. 689–694.
Jentzer A., Veyrard P., Roblin X., Saint-Sardos P., Rochereau N., Paul S., Bourlet T., Pozzetto B., Pillet S. // Microorganisms. 2020. V. 8. P. 1078.
Richardson A.K., Walker L.C., Cox B., Rollag H., Ro-binson B.A., Morrin H., Pearson J.F., Potter J.D., Pater-son M., Surcel H.M., Pukkala E., Currie M.J. // Clin. Transl. Oncol. 2020. V. 22. P. 585–602.
Lv Y.L., Han F.F., An Z.L., Jia Y., Xuan L.L., Gong L.L., Zhang W., Ren L.L., Yang S., Liu H., Liu L.H. // Intervirology. 2020. V. 63. P. 10–16.
Plotkin S.A., Boppana S.B. // Vaccine. 2019. V. 37. P. 7437–7442.
Permar S.R., Schleiss M.R., Plotkin S.A. // J. Virol. 2018. V. 92. P. e00030–18.
Kotton C.N. // Curr Opin Organ Transplant. 2019. V. 24. P. 469–475.
Sellar R.S., Peggs K.S. // Expert Opin. Biol. Ther. 2012. V. 12. P. 1161–1172.
Faure E., Galperine T., Cannesson O., Alain S., Gnemmi V., Goeminne C., Dewilde A., Béné J., Lasri M., Lessore de Sainte Foy C., Lionet A. // Medicine. 2016. V. 95. P. e5226.
Tan B.H. // Options Infect. Dis. 2014. V. 6. P. 256–270.
El Helou G., Razonable R.R. // Infect. Drug Resist. 2019. V. 12. P. 1481–1491.
Papanicolaou G.A., Silveira F.P., Langston A.A., Perei-ra M.R., Avery R.K., Uknis M., Wijatyk A., Wu J., Boeckh M., Marty F.M., Villano S. // Clin. Infect. Dis. 2019. V. 68. P. 1255–1264.
Piret J., Boivin G. // Antiviral Res. 2019. V. 163. P. 91–105.
Novikov M.S., Babkov D.A., Paramonova M.P., Khandazhinskaya A.L., Ozerov A.A., Chizhov A.O., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. // Bioorg. Med. Chem. 2013. V. 21. P. 4151–4157.
Babkov D.A., Khandazhinskaya A.L., Chizhov A.O., Andrei G., Snoeck R., Seley-Radtke K.L., Novikov M.S. // Bioorg. Med. Chem. 2015. V. 23. P. 7035–7044.
Maruyama T., Kozai S., Yamasaki T., Witvrouw M., Pannecouque C., Balzarini J., Snoeck R., Andrei G., De Clercq E. // Antivir. Chem. Chemother. 2003. V. 14. P. 271–279.
Maruyama T., Demizu Y., Kozai S., Witvrouw M., Pannecouque C., Balzarini J., Snoecks R., Andrei G., De Clercq E. // Nucleosides Nucleotides Nucleic Acids. 2007. V. 26. P. 1553–1558.
Novikov M.S., Valuev-Elliston V.T., Babkov D.A., Paramonova M.P., Ivanov A.V., Gavryushov S.A., Khandazhinskaya A.L., Kochetkov S.N., Pannecouque C., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. // Bioorg. Med. Chem. 2013. V. 21. P. 1150–1158.
Paramonova M.P., Khandazhinskaya A.L., Ozerov A.A., Kochetkov S.N., Snoeck R., Andrei G., Novikov M.S. // Acta Naturae. 2020. V. 12. P. 134–139.
Paramonova M.P., Snoeck R., Andrei G., Khandazhinskaya A.L., Novikov M.S. // Mendeleev Commun. 2020. V. 30. P. 602–603.
Baker B.R., Kelley J.L. // J. Med. Chem. 1970. V. 13. P. 458–461.